Boston Scientific shares are up almost 50% in the past six months, and the stock has more than doubled from two years ago. The question is whether this turnaround can keep turning…
Salix Pharmaceuticals and Valeant Pharmaceuticals have announced that they had entered into an agreement on their plan to merge based on a new price for Salix shares.
Stocks are still very close to all-time highs, and this bull market is now six years old. It turns out that some stocks made unusual moves last week.
A new bid from Endo International has made the merger situation around Salix Pharmaceuticals much more complicated.
Merrill Lynch has weighed in on Boston Scientific acquiring the American Medical Systems urology portfolio of Endo International.
Thursday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Coach, Garmin, Intelsat, Potbelly, SolarCity and Valero Energy.
The analysts at Piper Jaffray are very positive on four top specialty pharmaceutical stocks with potential for a strong fourth-quarter rally in their shares.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. on Monday, October 13, 2014.
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 10, 2014.
Endo International made an unsolicited buyout offer to Auxilium Pharmaceuticals, right after the latter announced that it had entered into an agreement to merge with QLT.
Chris Lange These are the top analyst upgrades and downgrades from 24/7 Wall St. for Tuesday, September 2, 2014.
ThinkstockIn a report out this week, the Goldman Sachs options research team listed its top 25 tactical trades for earning season. While the report includes many names, the trick is to identify…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical and UnitedHealth.
These are the top analyst upgrades, downgrades and initiations from Wall Street for Friday, May 2, 2014. They include Avanir, Avon, Broadcom, LinkedIn, Oracle and Wynn Resorts.
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to the…
